Objectives:To evaluate the clinical characteristics of patients who were followed in our clinic with the diagnosis of peripheral exudative hemorrhagic chorioretinopathy (PEHC).Materials and Methods:Medical records of 12 patients who were diagnosed with PEHC in İstanbul University İstanbul Faculty of Medicine, Department of Ophthalmology between July 2006 and June 2014 were reviewed retrospectively.Results:This study included 21 eyes of 12 patients. Four (33.3%) of the patients were male and 8 (66.7%) were female and ages ranged between 73 and 89 years. Eight (66.7%) of the patients were referred to us with the diagnosis of choroidal mass. Unilateral involvement was found in 3 and bilateral involvement in 9 patients. Temporal quadrants were involved in all eyes. Fifteen eyes (71.4%) had subretinal hemorrhage and hemorrhagic/serous retinal pigment epithelial detachment, 11 (52.4%) had lipid exudation, 5 (23.8%) had chronic retinal pigment epithelium alterations, 2 (9.5%) had subretinal fibrosis and 1 (4.8%) had vitreous hemorrhage. PEHC lesions were accompanied by drusen in 11 eyes (52.4%), geographic atrophy in 2 eyes (9.5%), and choroidal neovascularization scar in 2 eyes (9.5%). Treatment was done in both eyes of a patient for lesions which threatened the macula, in a patient with bilateral macular edema and in a patient with vitreous hemorrhage. The remaining eyes were followed-up without any treatment because the lesions did not threaten the macula and they showed no progression during follow-up.Conclusion:PEHC is a degenerative disease of peripheral retina that is seen in older patients, and signs of age-related macular degeneration (AMD) may accompany this pathology. Especially in patients with AMD findings, the peripheral retina must be evaluated carefully for existing PEHC lesions.

Results: Twenty-two patients were female, 20 patients were male and the mean age was 62.1±16 (34-81). LSL was performed once in 22 eyes (46.8%) and more than once in 25 eyes(53.2%). The mean number of LSL was 1.63±0.7. The mean IOP before trabeculectomy was 30.2 mmHg and it was 24.1±6.3 mmHg (14-42 mmHg) before LSL. The mean interval time between trabeculectomy and performance of suture lysis was 7.9±6.3 days. The mean IOPs before and immediately after laser suture lysis were 24.15±6.93 mmHg and 17.47±5.81 mmHg respectively in patients that LSL was performed once (p<0.001). The mean IOPs before and immediately after laser suture lysis were 23.96±7 mmHg and 16.6±4.61 mmHg respectively in patients that LSL was performed more than once (p<0.001). The difference was statistically significant in two groups (p<0.001). At the last visit, the mean IOP was 14.6±4.07 mmHg (4-25 mmHg) (p<0.001). The mean follow-up time was 21.4±20.01months (1-89 months). Conclusion:Laser suture lysis is a safe and effective method in the management of the patients in whom the target IOP was not reached after trabeculectomy and it can be performed more than once.